Inflammation Drugs Market Research Reports
Title | published | price | |
---|---|---|---|
Global Piroxicam Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 CountriesBy Maia Research "...... lication, and Leading 20 Countries covers and analyzes the potential of the global Piroxicam industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis, opport......" | 24-Aug-2021 | $4000 | |
China Ibuprofen Market Report & Forecast 2021-2027By QYResearch Group "...... 20 (%)
The global Ibuprofen market size is expected to growth from US$ 89 million in 2020 to US$ 109 million by 2027; it is expected to grow at a CAGR of 2.7% during 2021-2027.
The China Ibuprofen market was valued at US$ XX million in ......" | 24-Aug-2021 | $3400 | |
China Drugs For Sinusitis Market Report & Forecast 2021-2027By QYResearch Group "...... top five Drugs For Sinusitis companies in 2020 (%)
The global Drugs For Sinusitis market size is expected to growth from US$ 2161 million in 2020 to US$ 2764.6 million by 2027; it is expected to grow at a CAGR of 3.6% during 2021-2027.
......" | 19-Aug-2021 | $3400 | |
Global Mesalazine Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 CountriesBy Maia Research "...... pplication, and Leading 20 Countries covers and analyzes the potential of the global Mesalazine industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis, opp......" | 17-Aug-2021 | $4000 | |
China Celecoxib Market Report & Forecast 2021-2027By QYResearch Group "...... in 2020 (%)
The global Celecoxib market size is expected to growth from US$ 1175.4 million in 2020 to US$ 2062.6 million by 2027; it is expected to grow at a CAGR of 8.4% during 2021-2027.
The China Celecoxib market was valued at US$ XX......" | 17-Aug-2021 | $3400 | |
Global Ketoprofen Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027By QYResearch Group "...... Ketoprofen BPC (bulk pharmaceutical chemicals).
China is the largest Ketoprofen market with about 68% market share. Europe is follower, accounting for about 18% market share.
The key players are SANOFI-Aventis, Boehringer-Ingelheim, BEC......" | 13-Aug-2021 | $5900 | |
Global Ibuprofen Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027By QYResearch Group "...... LCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, with about 81% market shares.
China is the largest supplier of Ibuprofen, with a production market share nearly 48%. India is the second largest supplier of ......" | 11-Aug-2021 | $5900 | |
Global Celecoxib Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027By QYResearch Group "...... to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
Data show that more than 400 million people worldwide are c......" | 06-Aug-2021 | $5900 | |
Global Ibuprofen Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 CountriesBy Maia Research "...... lication, and Leading 20 Countries covers and analyzes the potential of the global Ibuprofen industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis and market entry strategy Analysis, opport......" | 05-Aug-2021 | $4000 | |
Global Adalimumab Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 CountriesBy Maia Research "...... ket revenue was xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026.
Global Adalimumab Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analy......" | 05-Aug-2021 | $4000 | |
|